Bafna Pharmaceuticals Limited share price
NSE: BAFNAPH · ISIN INE878I01022
Key numbers
- Market cap
- ₹ 828 Cr
- Current price
- ₹ 350.05
- 52-week high / low
- ₹ 350 / 95
- Stock P/E
- 106.4
- Book value
- ₹ 40.6
- Dividend yield
- 0.00%
- ROCE
- 11.7%
- ROE
- 12.3%
- Debt to equity
- 0.39
- Sales growth (3 yrs)
- 9.3%
- Profit growth (3 yrs)
- -0.7%
- 1-year return
- 153.3%
About Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. The company operates as a subsidiary of SRJR Lifesciences LLP.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 35 | 35 | 38 | 42 | 27 |
| Operating profit | 5 | 4 | 3 | 4 | 1 |
| Net profit | 3 | 3 | 2 | 3 | 0 |
| EPS (₹) | 1.43 | 1.32 | 0.78 | 1.16 | 0.03 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.